Roflumilast 500 MCG tablet 90S
Ended Awarded Last action
- Contract number
- SPE2DR26F6Y3W
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $12,963
Award facts
- Contract value 100% obligated
- $12,962.64 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $12,962.64 to AmerisourceBergen Drug Corp for the supply of Roflumilast 500 microgram tablets (90-count units). This firm fixed-price contract, executed on January 29, 2026, with an ultimate completion date of January 30, 2026, represents a small-value pharmaceutical procurement. The award is non-competitive with no set-aside designation, and the place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The contract is a child order under a larger Indefinite Delivery Contract vehicle with the Defense Logistics Agency.
AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc. (doing business as AmerisourceBergen), is a major pharmaceutical distributor serving the federal government's medical supply requirements. The company operates under a significant Indefinite Delivery Contract with DLA Troop Support Medical valued at $999,999,999.00 through December 2026, which serves as the vehicle for delivering comprehensive pharmaceutical products and medical supplies to support military healthcare programs globally. This delivery order for Roflumilast, a respiratory medication used in chronic obstructive pulmonary disease treatment, exemplifies the routine pharmaceutical procurement activities executed through this overarching contract framework to support Department of Defense medical facilities and programs.
Quick answers
Who was awarded contract SPE2DR26F6Y3W?
SPE2DR26F6Y3W was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 29, 2026.
How much is contract SPE2DR26F6Y3W worth?
The government has obligated $12,963 on SPE2DR26F6Y3W.
Is contract SPE2DR26F6Y3W an order under another contract?
Yes. SPE2DR26F6Y3W is a delivery order under SPE2DR25D3013, an indefinite delivery contract.
Was contract SPE2DR26F6Y3W competed?
The extent of competition for SPE2DR26F6Y3W was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award